Hyperfine (HYPR) Capital Expenditures (2021 - 2026)
Hyperfine (HYPR) posted Capital Expenditures of $69000.0 for Q1 2026, up 9.52% on a QoQ basis from $63000.0 in Q4 2025, and up 153.91% year-over-year from $27175.4 in Q1 2025.
Hyperfine (HYPR) Capital Expenditures (2021 - 2026) Analysis & Trends
Hyperfine's Capital Expenditures history runs 6 years deep, the most recent figure standing at $69000.0 for Q1 2026.
- Quarterly Capital Expenditures rose 153.91% year-over-year to $69000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (up 215.65% YoY) and the FY2025 annual result came in at $1.2 million, up 464.62% from the prior year.
- Capital Expenditures was $69000.0 for Q1 2026 at Hyperfine, up from $63000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.1 million in Q2 2025 and bottomed at -$896000.0 in Q4 2024.
- A 5-year average of $104764.7 and a median of $62000.0 in 2022 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2024 — Capital Expenditures slumped 347.51% — and 2025, when it jumped 16100.0%.
- Hyperfine's Capital Expenditures stood at $205000.0 in 2022, then soared by 76.59% to $362000.0 in 2023, then slumped by 347.51% to -$896000.0 in 2024, then surged by 107.03% to $63000.0 in 2025, then increased by 9.52% to $69000.0 in 2026.
- Business Quant data shows HYPR's Capital Expenditures at $69000.0 in Q1 2026, $63000.0 in Q4 2025, and $130000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Hyperfine | 92.81 Mn | 51.53 Mn | 1.98 Mn | 69,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69,000.00 |
| Mar 31, 2026 | 69,000.00 |
| Dec 31, 2025 | 63,000.00 |
| Dec 31, 2025 | 63,000.00 |
| Sep 30, 2025 | 130,000.00 |
| Sep 30, 2025 | 130,000.00 |
| Jun 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | -128,000.00 |
| Mar 31, 2025 | -128,000.00 |
| Dec 31, 2024 | -896,000.00 |
| Dec 31, 2024 | -896,000.00 |
| Sep 30, 2024 | -164,000.00 |
| Sep 30, 2024 | -164,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Mar 31, 2024 | 742,000.00 |
| Mar 31, 2024 | 742,000.00 |
| Dec 31, 2023 | 362,000.00 |
| Dec 31, 2023 | 362,000.00 |